IFNG and neoplasm: The ex vivo re-stimulation of TdLN cells from EG7-OVA tumor-bearing mice with SIINFEKL -a specific CD8+ T cell ovalbumin-derived peptide- showed that shCD5EμTg mice were more responsive than NonTg controls, as deduced from increased IFN-γ release.